Definitive Contract W911SR21C5001
Award Date
9/28/21
Potential Completion Date
9/27/24
Potential Value
$527K
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Arisan Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541330 - Engineering Services
PSC Category
AJ15 - General Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This $1,099,662.12 federal contract award to Arisan Therapeutics Inc. was made by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense under a Small Business Innovation Research (SBIR) Phase II program. The contract is a Firm Fixed Price Definitive Contract with the purpose of conducting research and development in support of the agency's chemical and biological defense mission. Arisan Therapeutics is a small disadvantaged business that has been...
This federal contract award was made by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) Program Phase I. The $149,972.66 firm fixed-price purchase order is for research and development services in support of chemical and biological defense programs. As a prime contractor, Clear Scientific has previously provided drug...
This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also...
This is a $3,247,731 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of a first-in-human therapeutic interfering particle targeting a respiratory virus, under DARPA's research programs. Autonomous Therapeutics has also been awarded an Indefinite Delivery Vehicle (IDV) by DARPA, with a potential value of $4,579,822, to develop and deliver therapeutic...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Physical Sciences Inc. (PSI), a for-profit research and development company. The definitive, firm-fixed-price contract has a ceiling value of $149,930.89 and a performance period ending on May 20, 2019. As an SBIR Phase I effort, this contract supports the initial research and development of an innovative technology by PSI. The company has...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Small Business Innovation Research (SBIR) Phase I contract to Real-Time Analyzers Inc., a for-profit small business. The firm fixed-price contract, valued at $149,999.21, is set aside for total small businesses. It was awarded on October 15, 2018 with a completion date of March 31, 2019. Real-Time Analyzers specializes in manufacturing compact and portable near-infrared (NIR) and Raman...
<p>This is a $1,700,320.72 cost-plus-fixed-fee contract awarded by the U.S. Army Contracting Command (ACC) Aberdeen Proving Ground to Exicure, Inc., a small business concern, under the SBIR Phase II program. The contract is for research and development entitled "Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics" and has a period of performance through January 31, 2016. This SBIR Phase II contract was set aside for small businesses.</p>
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
<p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>
This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...